Atara Biotherapeutics Statistics
NASDAQ: ATRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.33-0.01 (-0.16%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Atara Biotherapeutics by the numbers
Atara Biotherapeutics has a market capitalization of $64.5 million based on 10.19M shares outstanding. With trailing EPS of $-1.12, Atara Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.4% below its 50-day average and 19.6% below its 200-day average.
Average daily trading volume is 35.46K shares, or about $224,487 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ATRA valuation vs. peer median
| Metric | ATRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $64.49M | $58.78M | +10% |
| Avg. volume | 35.46K | 1.08M | -97% |
Peer median across 8 companies: TNYA, NMRA, CRDF, CSBR, CHRS, OKYO, CGTX, AVXL.
Valuation
- Market cap
- $64.49M
- Forward P/E
- 3.96
- Price / sales (latest FY)
- 0.53
- EPS (TTM)
- $-1.12
- Shares outstanding
- 10.19M
Price and trading
- Previous close
- 6.34
- Open
- 6.25
- Day range
- 6.25 – 6.85
- 52-week range
- 3.92 – 19.15
- 52-week change
- -53.73%
- Beta
- —
- Volume
- 36.42K
- Average volume
- 35.46K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 64.49M
- Forward Pe
- 3.96
- Eps
- -1.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.15
- Week52 Low
- 3.92
- Avg Volume
- 35,464.00
- Shares Outstanding
- 10.19M
- Ma50
- 8.61
- Ma200
- 7.87
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -66.94%
- Pct From52w Low
- 61.48%